PERRIGO (PRGO)

Perrigo’s product portfolio spans categories such as allergy relief, cough and cold treatments, pain relief, digestive health, smoking cessation, infant nutrition, oral care, skincare, and women’s health. In North America, its scale in private-label manufacturing allows retailers to offer lower-cost products across essential self-care categories. Customers include large retail chains and e-commerce platforms, making Perrigo an important supplier within the consumer healthcare supply chain.

Outside North America, the company participates in branded consumer health markets across Europe, Australia, and parts of Asia. Its international brands include names such as Compeed, Solpadeine, Coldrex, and ellaOne, giving the business exposure to both retailer-led private-label demand and established branded self-care franchises.

Perrigo has reshaped its portfolio in recent years to concentrate on consumer self-care, moving away from animal health and prescription generic pharmaceuticals. This focus positions the company within a market driven by consumers seeking accessible treatments for everyday health needs, healthcare systems encouraging self-management where appropriate, and retailers expanding their own-brand offerings. Perrigo’s results depend on product innovation, manufacturing execution, retailer relationships, regulatory compliance, and competition across both branded and private-label categories.